Laboratory Testing for Easy Bruising on Lexapro
Order a complete blood count (CBC), prothrombin time (PT), activated partial thromboplastin time (aPTT), and peripheral blood smear as initial laboratory tests for a patient developing easy bruising while taking Lexapro (escitalopram).
Rationale and Clinical Context
SSRIs like Lexapro can cause bleeding and bruising through serotonin depletion in platelets, which impairs platelet aggregation and hemostasis 1. While the FDA label for Lexapro does not specifically list bruising as a common adverse effect in its detailed tables, this is a recognized class effect of SSRIs that warrants systematic evaluation 2.
Initial Laboratory Workup
The standard approach for evaluating new-onset easy bruising requires:
- Complete blood count (CBC) - to assess platelet count and identify thrombocytopenia
- Peripheral blood smear - to evaluate platelet morphology and rule out qualitative platelet abnormalities
- Prothrombin time (PT) - to assess the extrinsic coagulation pathway
- Activated partial thromboplastin time (aPTT) - to assess the intrinsic coagulation pathway
These four tests constitute the recommended initial hemostasis screening panel 3, 4.
Interpreting Results
If all initial tests are normal (PT, aPTT, CBC with normal platelet count), this pattern suggests a platelet function disorder, which is the most likely mechanism for SSRI-induced bruising 4. The mechanism involves:
- Blockade of serotonin uptake into platelets by escitalopram
- Depletion of platelet serotonin stores
- Impaired serotonin-mediated amplification of platelet aggregation
- Increased bleeding tendency despite normal platelet count 2
If PT and aPTT are prolonged, consider adding fibrinogen level and pursuing evaluation for coagulopathy or liver dysfunction 3, 4.
Additional Considerations
When to Consider von Willebrand Disease Testing
If the patient has a strong personal or family history of mucocutaneous bleeding (nosebleeds, heavy menstrual bleeding, prolonged bleeding from minor cuts) and initial tests are normal, consider ordering:
- von Willebrand factor antigen (VWF:Ag)
- von Willebrand factor ristocetin cofactor activity (VWF:RCo)
- Factor VIII coagulant activity
This is particularly important because SSRIs may unmask an underlying mild bleeding disorder like von Willebrand disease 5.
Clinical Pitfalls to Avoid
- Do not assume normal platelet count excludes a bleeding problem - platelet function disorders present with normal counts but abnormal function 4, 6
- Review all medications - check for concurrent use of NSAIDs, aspirin, anticoagulants, or other antiplatelet agents that could synergize with SSRI effects
- Document the bruising pattern - ask the patient to photograph bruises to establish severity and progression
- Consider non-accidental trauma in vulnerable populations, though medication effect is more likely in this context 3
When to Refer to Hematology
Refer to a hematologist if:
- Initial laboratory workup reveals abnormalities
- Suspicion for bleeding disorder remains high despite normal initial tests
- Bruising is severe, progressive, or associated with other bleeding symptoms
- Patient requires continued SSRI therapy but has significant bleeding complications 3, 4
The FDA label notes that laboratory changes with Lexapro treatment showed "no clinically important changes in laboratory test parameters" in controlled trials 1, but individual patients may still develop clinically significant bleeding complications requiring full hematologic evaluation.